NCT06814756View on ClinicalTrials.gov

Bacteriophage Therapy for Morganella Morganii Prosthetic Joint Infection

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

March 26, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Prosthetic Joint Infections of Hip

Interventions

BIOLOGICAL

phage therapy

Single anti-Morganella morganii bacteriophage drug product

Trial Locations (1)

Unknown

Foothills Medical Centre, University of Calgary, Calgary

Sponsors

Collaborators (1)

Qeen Biotechnologies

All Listed Sponsors

collaborator

Qeen Biotechnologies

INDUSTRY

lead

University of Calgary

OTHER

NCT06814756 - Bacteriophage Therapy for Morganella Morganii Prosthetic Joint Infection | Biotech Hunter | Biotech Hunter